Targeted 1,3-dipolar cycloaddition with acrolein for cancer prodrug activation

Journal:
Chemical Science
Published:
DOI:
10.1039/d0sc06083f
Affiliations:
6
Authors:
8
Institutions Authors Share
Tokyo Institute of Technology (Tokyo Tech), Japan
3.583333
0.45
Hokkaido University, Japan
2.000000
0.25
RIKEN Biofunctional Synthetic Chemistry Laboratory, Japan
1.083333
0.14
RIKEN Cluster for Pioneering Research (CPR), Japan
1.083333
0.14
KFU-RIKEN Biofunctional Chemistry Laboratory, Russia
0.250000
0.03